Klein's Lobbying Group Opposes Affordable Access Bill
The private stem cell lobbying group run by Robert Klein, who also serves as chairman of the $3 billion state stem cell agency, is formally opposing legislation aimed at ensuring that state-financed therapies are affordable and accessible to Californians.
The opposition of Americans for Cures was noted today in the legislative staff analysis of SB1565 b…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.